It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Aging is characterized by a gradual loss of function occurring at the molecular, cellular, tissue and organismal levels. At the chromatin level, aging associates with progressive accumulation of epigenetic errors that eventually lead to aberrant gene regulation, stem cell exhaustion, senescence, and deregulated cell/tissue homeostasis. Nuclear reprogramming to pluripotency can revert both the age and the identity of any cell to that of an embryonic cell. Recent evidence shows that transient reprogramming can ameliorate age-associated hallmarks and extend lifespan in progeroid mice. However, it is unknown how this form of rejuvenation would apply to naturally aged human cells. Here we show that transient expression of nuclear reprogramming factors, mediated by expression of mRNAs, promotes a rapid and broad amelioration of cellular aging, including resetting of epigenetic clock, reduction of the inflammatory profile in chondrocytes, and restoration of youthful regenerative response to aged, human muscle stem cells, in each case without abolishing cellular identity.
Aging involves gradual loss of tissue function, and transcription factor (TF) expression can ameliorate this in progeroid mice. Here the authors show that transient TF expression reverses age-associated epigenetic marks, inflammatory profiles and restores regenerative potential in naturally aged human cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Stanford University School of Medicine, Institute for Stem Cell Biology and Regenerative Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University School of Medicine, Department of Obstetrics and Gynecology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University School of Humanities and Sciences, Department of Applied Physics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
2 Stanford University School of Medicine, Department of Neurology and Neurological Sciences, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University School of Medicine, Paul F. Glenn Center for the Biology of Aging, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Veterans Affairs Palo Alto Health Care System, Center for Tissue Regeneration, Repair and Restoration, Palo Alto, USA (GRID:grid.280747.e) (ISNI:0000 0004 0419 2556); Molecular Medicine Research Institute, Sunnyvale, USA (GRID:grid.486808.a) (ISNI:0000 0004 0635 6745)
3 Stanford University School of Medicine, Department of Orthopedic Surgery, Sanford, USA (GRID:grid.486808.a)
4 Stanford University School of Medicine, Department of Neurology and Neurological Sciences, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University School of Medicine, Paul F. Glenn Center for the Biology of Aging, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Veterans Affairs Palo Alto Health Care System, Center for Tissue Regeneration, Repair and Restoration, Palo Alto, USA (GRID:grid.280747.e) (ISNI:0000 0004 0419 2556); Stanford University School of Medicine, Department of Genetics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
5 Stanford University School of Medicine, Department of Neurology and Neurological Sciences, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University School of Medicine, Paul F. Glenn Center for the Biology of Aging, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Veterans Affairs Palo Alto Health Care System, Center for Tissue Regeneration, Repair and Restoration, Palo Alto, USA (GRID:grid.280747.e) (ISNI:0000 0004 0419 2556)
6 Stanford University School of Medicine, Department of Orthopedic Surgery, Sanford, USA (GRID:grid.280747.e); VA Palo Alto Health Care System, Palo Alto, USA (GRID:grid.280747.e) (ISNI:0000 0004 0419 2556)
7 University of California, Department of Human Genetics David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Fielding School of Public Health, UCLA, Department of Biostatistics, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
8 Stanford University, Department of Bioengineering, Department of Chemical and Systems Biology, ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
9 Stanford University School of Medicine, Department of Orthopedic Surgery, Sanford, USA (GRID:grid.168010.e)
10 Stanford University School of Medicine, Institute for Stem Cell Biology and Regenerative Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University School of Medicine, Department of Obstetrics and Gynecology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)